Proto Labs, Inc. (PRLB) Expected to Announce Quarterly Sales of $91.75 Million
Equities analysts predict that Proto Labs, Inc. (NYSE:PRLB) will report sales of $91.75 million for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Proto Labs’ earnings, with the lowest sales estimate coming in at $91.60 million and the highest estimate coming in at $91.89 million. Proto Labs posted sales of $72.35 million in the same quarter last year, which suggests a positive year over year growth rate of 26.8%. The firm is expected to report its next earnings results before the market opens on Thursday, February 8th.
According to Zacks, analysts expect that Proto Labs will report full-year sales of $91.75 million for the current fiscal year, with estimates ranging from $338.00 million to $342.20 million. For the next year, analysts forecast that the business will post sales of $438.39 million per share, with estimates ranging from $438.27 million to $438.50 million. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for Proto Labs.
Proto Labs (NYSE:PRLB) last released its quarterly earnings results on Thursday, October 26th. The industrial products company reported $0.56 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.04. The firm had revenue of $88.10 million during the quarter, compared to analyst estimates of $85.68 million. Proto Labs had a return on equity of 11.63% and a net margin of 14.53%. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.51 EPS.
Several research firms have recently commented on PRLB. Zacks Investment Research raised Proto Labs from a “hold” rating to a “buy” rating and set a $120.00 price target for the company in a research report on Saturday, January 13th. Piper Jaffray Companies reissued a “hold” rating and issued a $84.00 price target on shares of Proto Labs in a research report on Thursday, December 14th. Craig Hallum set a $92.00 price target on Proto Labs and gave the stock a “hold” rating in a research report on Monday, November 27th. Finally, BidaskClub lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 6th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. Proto Labs currently has an average rating of “Hold” and a consensus target price of $85.25.
In other news, Director Rainer Gawlick sold 500 shares of the business’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $102.75, for a total value of $51,375.00. Following the completion of the transaction, the director now directly owns 10,925 shares of the company’s stock, valued at approximately $1,122,543.75. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP John B. Tumelty sold 13,556 shares of the company’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $92.07, for a total value of $1,248,100.92. The disclosure for this sale can be found here. Over the last three months, insiders sold 19,556 shares of company stock valued at $1,814,101. Corporate insiders own 7.78% of the company’s stock.
Large investors have recently made changes to their positions in the stock. Victory Capital Management Inc. increased its position in Proto Labs by 17.7% during the 2nd quarter. Victory Capital Management Inc. now owns 2,323 shares of the industrial products company’s stock valued at $156,000 after buying an additional 349 shares in the last quarter. Cubist Systematic Strategies LLC acquired a new position in Proto Labs during the 3rd quarter valued at about $238,000. Hanseatic Management Services Inc. acquired a new position in Proto Labs during the 3rd quarter valued at about $243,000. Pinebridge Investments L.P. increased its position in Proto Labs by 0.9% during the 2nd quarter. Pinebridge Investments L.P. now owns 3,212 shares of the industrial products company’s stock valued at $216,000 after buying an additional 29 shares in the last quarter. Finally, Advisor Group Inc. increased its position in Proto Labs by 3.6% during the 2nd quarter. Advisor Group Inc. now owns 3,409 shares of the industrial products company’s stock valued at $230,000 after buying an additional 119 shares in the last quarter.
Proto Labs (NYSE:PRLB) opened at $111.70 on Friday. The company has a market capitalization of $2,980.00, a price-to-earnings ratio of 63.47, a PEG ratio of 2.36 and a beta of 1.07. Proto Labs has a 1 year low of $48.00 and a 1 year high of $111.80.
About Proto Labs
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.